www.fdanews.com/articles/69112-sentigen-holding-reports-sale-of-specialty-media-division
Sentigen Holding Reports Sale of Specialty Media Division
February 23, 2005
Sentigen Holding has sold the Specialty Media Division of its wholly owned subsidiary, Cell & Molecular Technologies to Chemicon International, a wholly owned subsidiary of Serologicals Corporation. Under the terms of the agreement, Serologicals agreed to pay Sentigen Holding $6.5 million in cash, subject to certain post-closing adjustments and escrow, for the assets of the division. In addition to the purchase price Serologicals has retired the mortgage note with a balance of $243,310 on the division's facility at 580 Marshall Street, Phillipsburg, N.J. 08865.